All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Radiofrequency ablation using the second-generation temperature-controlled diamond tip system in paroxysmal and persistent atrial fibrillation: results from FASTR-AF

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F23%3A00009418" target="_blank" >RIV/00023884:_____/23:00009418 - isvavai.cz</a>

  • Result on the web

    <a href="https://link-springer-com.ezproxy.lib.cas.cz/article/10.1007/s10840-022-01234-9" target="_blank" >https://link-springer-com.ezproxy.lib.cas.cz/article/10.1007/s10840-022-01234-9</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s10840-022-01234-9" target="_blank" >10.1007/s10840-022-01234-9</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Radiofrequency ablation using the second-generation temperature-controlled diamond tip system in paroxysmal and persistent atrial fibrillation: results from FASTR-AF

  • Original language description

    Background Catheter ablation (CA) technology development reflects the need to improve the effectiveness of atrial fibrillation (AF) treatment. Recently, the DiamondTemp Ablation (DTA) RF generator software was updated with a more responsive power ramp. Methods DIAMOND FASTR-AF was a prospective, single-arm, multicenter trial. This study sought to characterize the performance of the updated DTA system for the treatment of patients with drug-refractory paroxysmal and persistent AF (PAF and PsAF). The primary effectiveness endpoint was freedom from atrial arrhythmia recurrence following a 90-day blanking period through 12 months, and the primary safety endpoint was a composite of serious adverse events. Results In total, 60 subjects (34 PAF and 26 PsAF) underwent CA at three centers. Patients were 71.7% male, (age 63.9 +/- 10.2 years, with an AF diagnosis duration 3.1 +/- 3.9 years and left atrial size 4.4 +/- 0.8 cm). Pulmonary vein isolation-only ablation strategy was performed in 34 (56.7%) subjects. The procedural characteristics show a procedure time 90.8 +/- 31.6 min, total RF time 14.7 +/- 7.7 min, ablation duration 10.7 +/- 3.6 s, and fluid infusion 284.7 +/- 111.5 ml. The serious adverse event rate was 8.3% (5/60), 3 pulmonary edema and 2 extended hospitalizations. Freedom from atrial arrhythmia recurrence was achieved in 67.6% of subjects by 12 months. Conclusions The updated DTA system demonstrated long-term safety and effectiveness through 12 months of post-ablation follow-up for patients with atrial fibrillation. Additionally, procedures were demonstrated to be highly efficient with short procedure times and low levels of fluid infusion. Trial registration Sponsored by Medtronic, Inc.; FASTR-AF ClinicalTrials.gov; NCT03626649.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Interventional Cardiac Electrophysiology

  • ISSN

    1383-875X

  • e-ISSN

  • Volume of the periodical

    66

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    9

  • Pages from-to

    343-351

  • UT code for WoS article

    000796802800002

  • EID of the result in the Scopus database

    2-s2.0-85130308142